Log on / register
Feedback | Support | My details

Pre-publication history

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

Andrew J Vickers email, Angel M Cronin email, Gunnar Aus email, Carl-Gustav Pihl email, Charlotte Becker email, Kim Pettersson email, Peter T Scardino email, Jonas Hugosson email and Hans Lilja email

BMC Medicine 2008, 6:19doi:10.1186/1741-7015-6-19

Pre-publication versions of this article and reviewers' reports

Original submission - Version 1Manuscript25 Jan 2008
Reviewer's ReportSteven Narod25 Feb 2008
Reviewer's ReportRobert B. Nadler20 Mar 2008
Reviewer's ReportRobert B. Nadler20 Mar 2008
Resubmission - Version 2ManuscriptAuthors' comments14 Apr 2008
Reviewer's ReportRobert B. Nadler30 Apr 2008
Reviewer's ReportSteven Narod07 May 2008
Resubmission - Version 3ManuscriptAuthors' comments27 May 2008
Resubmission - Version 4Manuscript24 Jun 2008
Resubmission - Version 5Manuscript26 Jun 2008
Resubmission - Version 6Manuscript26 Jun 2008
Accepted08 Jul 2008
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.